- Home
- HBIO vs RENB Comparison
HBIO vs RENB Comparison
Compare HBIO & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- RENB
- Stock Information
- Founded
- HBIO 1901
- RENB 2011
- Country
- HBIO United States
- RENB United States
- Employees
- HBIO N/A
- RENB N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- HBIO Industrials
- RENB Health Care
- Exchange
- HBIO Nasdaq
- RENB Nasdaq
- Market Cap
- HBIO 106.4M
- RENB 145.9M
- IPO Year
- HBIO 2000
- RENB N/A
- Fundamental
- Price
- HBIO $2.39
- RENB $0.74
- Analyst Decision
- HBIO
- RENB
- Analyst Count
- HBIO 0
- RENB 0
- Target Price
- HBIO N/A
- RENB N/A
- AVG Volume (30 Days)
- HBIO 136.5K
- RENB 743.9K
- Earning Date
- HBIO 11-05-2024
- RENB 10-10-2024
- Dividend Yield
- HBIO N/A
- RENB N/A
- EPS Growth
- HBIO N/A
- RENB N/A
- EPS
- HBIO N/A
- RENB N/A
- Revenue
- HBIO $101,125,000.00
- RENB N/A
- Revenue This Year
- HBIO N/A
- RENB N/A
- Revenue Next Year
- HBIO $2.68
- RENB N/A
- P/E Ratio
- HBIO N/A
- RENB N/A
- Revenue Growth
- HBIO N/A
- RENB N/A
- 52 Week Low
- HBIO $2.32
- RENB $0.40
- 52 Week High
- HBIO $5.56
- RENB $5.25
- Technical
- Relative Strength Index (RSI)
- HBIO 38.02
- RENB 59.76
- Support Level
- HBIO $2.38
- RENB $0.40
- Resistance Level
- HBIO $2.55
- RENB $1.01
- Average True Range (ATR)
- HBIO 0.12
- RENB 0.11
- MACD
- HBIO 0.00
- RENB 0.05
- Stochastic Oscillator
- HBIO 17.07
- RENB 56.81
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of cancer, HIV, and HBV with the intent to manufacture said products.